INDORAMA VEN -F-
There is no Profile data available for I93.MU.
INDORAMA VEN -F- (I93) - Total Liabilities
Latest total liabilities as of December 2025: €394.53 Billion EUR
Based on the latest financial reports, INDORAMA VEN -F- (I93) has total liabilities worth €394.53 Billion EUR as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
INDORAMA VEN -F- - Total Liabilities Trend (2016–2025)
This chart illustrates how INDORAMA VEN -F-'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
INDORAMA VEN -F- Competitors by Total Liabilities
The table below lists competitors of INDORAMA VEN -F- ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
YUEXIU TRANSPOR (GZ3.SG)
STU:GZ3
|
Germany | €21.65 Billion |
|
Avalanche International Corp
PINK:AVLP
|
USA | $2.90 Million |
|
SKYCITY ENTERT
BE:RX4
|
Germany | €1.48 Billion |
|
Statera Biopharma Inc
PINK:STAB
|
USA | $22.92 Million |
|
WGHT WTCHER INTL (WW6.SG)
STU:WW6
|
Germany | €1.69 Billion |
|
Lloyds Enterprises Limited
NSE:LLOYDSENT
|
India | ₹13.78 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down INDORAMA VEN -F-'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how INDORAMA VEN -F-'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for INDORAMA VEN -F- (2016–2025)
The table below shows the annual total liabilities of INDORAMA VEN -F- from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €394.53 Billion | -2.01% |
| 2024-12-31 | €402.62 Billion | -2.29% |
| 2023-12-31 | €412.06 Billion | -2.58% |
| 2022-12-31 | €422.99 Billion | +14.07% |
| 2021-12-31 | €370.82 Billion | +16.77% |
| 2020-12-31 | €317.56 Billion | +31.01% |
| 2019-12-31 | €242.40 Billion | +6.62% |
| 2018-12-31 | €227.34 Billion | +39.15% |
| 2017-12-31 | €163.37 Billion | -1.92% |
| 2016-12-31 | €166.57 Billion | -- |